The Synthetic Biology Innovation Network

Biopharma

SynBioBeta 2021 Live! Because being in the same room is better than being on the same Zoom!

Editors' picks

Investors Bet Big with Fungi Alternative Protein Company Enough

In the race to make alternative meat mainstream, it’s less a question of if it will happen, but how. Earlier this year, a report by the Boston Consulting Group and Blue Horizon Corporation predicted that regular meat...

Is Tissue Engineering The Future of Cruelty-Free Fashion?

So You Want to Sell Your Genome As an NFT? Read This First

In the past few months, non-fungible tokens, or NFTs, have become the hot new investment trend, generating skepticism, confusion, and millions of dollars. Jack Dorsey, the founder and CEO of Twitter, auctioned off his...

The Search for a Cancer Vaccine: Have We Been Doing It All Wrong?

Can Microbes Clean The World’s Most Polluted Waterways?

Next on the Menu: Cellular Agriculture Could “Domesticate” Any Animal on the Planet

Animal breeding, maintenance, and slaughter have been integral parts of agricultural systems around the world for over 10,000 years. Today, raising livestock generates 14.5% of global greenhouse gas emissions and is...

The DNA Industry Is Going Cell-Free

Who Owns CRISPR in 2021? It’s Even More Complicated Than You Think

The question of who owns CRISPR, the genetic editing tool expected to transform modern medicine, is a confusing mess of legal battles, obscure naming conventions, and subtle variations in molecular form and function...

Visualizing the Future: Spatialomics Transforms Study of Gene Expression

a strand of neon white dna with a black background

Living Power: This Bio-Battery Is Harnessing the Power of DNA

View all posts

Press releases

Protera Announces Final Close of Its $10M Series A Led by Sofinnova Partners

AI-powered startup to use funds to advance its protein platform as company moves towards commercializing its product portfolio Mexico’s Bimbo Group and the ICL Group join financing round July 28, 2021 08:00 AM Eastern...

Deep Genomics Raises $180M in Series C Financing

– Company expands AI discovery platform for ‘Programmable’ RNA therapeutics and supports advancement of its portfolio into the clinic – Oversubscribed round led by SoftBank Vision Fund 2, with CPP...

Prokarium Appoints Kristen Albright as Chief Executive Officer

July 27, 2021 04:00 AM Eastern Daylight Time LONDON–(BUSINESS WIRE)–Prokarium, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, today announced the appointment of Kristen...

Nobell Foods Raises $75M Series B To Introduce Cheese Made From Plants

CEO Magi Richani’s Bold Vision for Cheese Challenges Status Quo Definitions of “Plant-Based” SAN FRANCISCO, July 27, 2021 /PRNewswire/ — Nobell Foods raises $75M to introduce delicious cheeses...

Twist Bioscience Incorporates MOLCURE AI Technology to Augment Therapeutic Antibody Discovery

SOUTH SAN FRANCISCO, Calif. & KAWASAKI, Japan–(BUSINESS WIRE)–Jul. 26, 2021– Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high...

BiomX Inc. Announces $15 Million Registered Direct Offering

NESS ZIONA, Israel, July 26, 2021 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that...

Xenetic Biosciences, Inc. Announces $12.5 Million Private Placement Priced at a Premium to Market

FRAMINGHAM, MA / ACCESSWIRE / July 26, 2021 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) (“Xenetic” or the “Company”), a biopharmaceutical company focused on advancing XCART™, a personalized CAR T...

Twist Bioscience Now Shipping Synthetic RNA Positive Controls for Delta (B.1.617.2) SARS-CoV-2 Variant for Development of Accurate Diagnostic Tests

July 22, 2021 08:00 AM Eastern Daylight Time SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high...

Caribou Biosciences Announces Pricing of Upsized Initial Public Offering

July 22, 2021 09:09 PM Eastern Daylight Time BERKELEY, Calif.–(BUSINESS WIRE)–Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today the pricing...

Codex DNA Announces Licensing and Supply Deal with TriLink Biotechnologies for CleanCap® mRNA Capping Technology

SAN DIEGO, July 21, 2021 (GLOBE NEWSWIRE) — Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced a licensing and supply agreement with TriLink Biotechnologies...

Berkeley Lights announces technology collaboration to accelerate and improve gene therapy viral vector development and manufacturing

EMERYVILLE, Calif., July 21, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI) today announced a strategic collaboration with Thermo Fisher Scientific aimed at addressing challenges in commercial-scale...

ClexBio Oversubscribes Financing Round Totalling USD 2.2M to Develop Engineered Human Blood Vessel Transplants

July 20, 2021 11:53 AM Eastern Daylight Time OSLO, Norway–(BUSINESS WIRE)–ClexBio, a start-up developing bioengineered human blood vessels for transplant, has secured US$2.2m in seed funding from private...